Sarah Derks

Dutch Cancer Society — Netherlands

Medicine · Health Sciences

24h-index2.9kcitations188works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(80), Esophageal Cancer Research and Treatment(74), Cancer Immunotherapy and Biomarkers(32), Lung Cancer Treatments and Mutations(32), Helicobacter pylori-related gastroenterology studies(27)

Publications187 total

Supplementary Figures from A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
2025Open Access
Supplementary Tables from A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
2025Open Access
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population‐based comparison
International Journal of Cancer·2025· 1 citedOpen Access
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real‐world matched comparison of overall survival
International Journal of Cancer·2025· 1 citedOpen Access
Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approach
BMC Cancer·2025Open Access
2501 Radical hypofractionated radiotherapy with capecitabine for unfit esophageal cancer patients: a phase II study (CRADLE / NL75846.029.20).
Radiotherapy and Oncology·2025
2641 Treatment of cN3M0 esophageal cancer: a nationwide study using propensity score matching
Radiotherapy and Oncology·2025
Peritoneal resident macrophages constitute an immunosuppressive environment in peritoneal metastasized colorectal cancer
Nature Communications·2025· 6 citedOpen Access
Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence
British Journal of Cancer·2025Open Access
Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project
ESMO Open·2025· 3 citedOpen Access
Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium
Journal of Cancer Education·2025Open Access
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study
European Journal of Cancer·2025· 1 citedOpen Access
Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands
EClinicalMedicine·2025· 10 citedOpen Access
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling
Genome Research·2025· 7 citedOpen Access
Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression
Gastric Cancer·2025· 3 citedOpen Access
226P Profiling of gastric adenocarcinomas from EU and LATAM countries identifies distinct tumor immune subgroups and a central role of the tumor microbiome in shaping the immune microenvironment
Immuno-Oncology Technology·2024Open Access
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes
International Journal of Radiation Oncology*Biology*Physics·2024· 4 citedOpen Access
Gastric cancer hospital-based registry: real-world gastric cancer data from Latin America and Europe
ESMO Gastrointestinal Oncology·2024· 5 citedOpen Access
Supplementary Figures from A bispecific γδ T-cell engager targeting EGFR activates a potent Vγ9Vδ2 T cell–mediated immune response against EGFR-expressing tumors
2024Open Access
Supplementary Figures from A bispecific γδ T-cell engager targeting EGFR activates a potent Vγ9Vδ2 T cell–mediated immune response against EGFR-expressing tumors
2024Open Access
page 1 of 10Next →

Frequent Co-authors

Hanneke W.M. van Laarhoven(13), Adam J. Bass(11), Manon van Engeland(10), James G. Herman(9), Nicole C.T. van Grieken(9), Adriaan P. de Bruı̈ne(7), Tanja D. de Gruijl(7), Victor L. Thijssen(7), Mark I. van Berge Henegouwen(7), Leonie K. de Klerk(6), Maarten F. Bijlsma(6), Ruben S. A. Goedegebuure(6), Hanneke W. M. van Laarhoven(6), Gerrit A. Meijer(5), Nadia Haj Mohammad(5), Tom van den Ende(5), Tessa S. Groen-van Schooten(5), Rob H.A. Verhoeven(5), Tania Fleitas(4), Beatriz Carvalho(4)